Reactive Arthritis News

Mylan has expanded its voluntary recall to the hospital / user level for select lots of methotrexate, gemcitabine and other products designed for injection use due to the presence of visible particulate matter, according to a company press release.

Industrial pollution may be linked to anti-cyclic citrullinated peptide antibodies, according to research from Sasha Bernatsky, MD, and colleagues presented at the Canadian Rheumatology Association Annual Meeting.

CHICAGO - About 13% of patients with rheumatic diseases have interstitial lung disease, and pulmonary toxicity is associated with certain rheumatic therapies, including methotrexate, according to information presented at the American College of Rheumatology State-of-the-Art Clinical Symposium, here.

CHICAGO — During the American College of Rheumatology State-of-the-Art Clinical Symposium, Beth L. Jonas, MD, discussed the common viral illnesses that may present alongside inflammatory rheumatic diseases.

CHICAGO — Statins can cause myalgia, and symptoms can take months or years to resolve, according to Andrew L. Mammen, MD, PhD, who presented research at the American College of Rheumatology State-of-the-Art Clinical Symposium.

Patients with the chikungunya virus had similar clinical presentation and T cell counts compared to patients with new, symmetric rheumatoid arthritis, according to recently published research.

Patients at a single rheumatology tertiary center in the United Kingdom gave correct responses about half of the time, on average, to questions about clinical trial details, but respondents who had higher knowledge about clinical trials were more willing to participate in research, according to recently published study findings.

The inappropriate use of NSAIDs, defined by the Italian Agency of Medicines as use for 21 days or more, for chronic pain associated with osteoarthritis, rheumatoid arthritis and other conditions may be prevalent in European patients, according to recently published research.

Fatigue was reported by 98% of patients with autoimmune disorders polled, and fatigue that prevented completion of everyday tasks was reported by 68% of the patients, according to a press release from the American Autoimmune Disease Related Diseases Association.

Patients with adult-onset Still disease who developed macrophage activation syndrome had poorer outcomes than patients who did not, according to a study from the Ajou University School of Medicine in Suwon, Korea.